Speech Therapy for Hearing Loss

(Project PAIR Trial)

Overseen By Jena McDaniel

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: Vanderbilt University

Disqualifiers: Motor speech disorder, Oral structural disorder, Autism, ADHD, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 3

Duration: 6 weeks

10 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing children. To address these objectives, the following research questions will be investigated: 1. Does drill-based articulation therapy, administered by a speech-language pathologist, improve speech sound production in DHH children when parent-implemented BTSR is concurrently utilized at home? 2. Does the combination of parent-implemented BTSR and clinician-led traditional articulation therapy result in generalization of speech sound accuracy at the conversation level?

Are You a Good Fit for This Trial?

This trial is for children aged 4 to almost 10 years with permanent, prelingual sensorineural hearing loss who primarily use spoken English at home. They must have a certain level of cognitive and language comprehension abilities (scores ≥70 on specific tests) and have at least two speech sound errors that can be targeted in therapy.

Inclusion Criteria

My Leiter test score is 70 or higher.

My listening comprehension score is 70 or higher.

I have at least two speech errors according to norms.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline

Initial assessment of speech sound production and baseline data collection

2 weeks

1 visit (in-person)

Treatment

Participants receive parent-implemented Broad Treatment Speech Recast and clinician-led articulation therapy

6 weeks

Weekly visits (in-person)

Follow-up

Participants are monitored for generalization of speech sound accuracy at the conversation level

4 weeks

2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

• Broad Target Speech Recast
• Traditional Speech Therapy

Trial Overview The study is testing the effectiveness of parents helping their kids with speech exercises at home (Broad Target Speech Recast), along with traditional speech therapy led by professionals. The goal is to see if this combination improves how well these children pronounce words.

How Is the Trial Designed?

Group I: Articulation Therapy Experimental Treatment 2 Interventions

Participants engage in two conditions: (1) Parent-implemented Broad Target Speech Recast (BTSR), (2) Parent-implemented BTSR combined with clinician-implemented speech therapy This is a nonconcurrent multiple probe single-case experimental design with staggered introduction of conditions across participants. All participants receive both interventions, but the interventions are introduced in separate phases and evaluated independently and in combination. This is not a crossover or parallel group design. Rather than having separate arms or randomization, each participant serves as their own control over time, allowing for individualized evaluation of intervention effects.

Who Is Running the Clinical Trial?

Vanderbilt University

Lead Sponsor

Trials

714

Recruited

6,143,000+